Trial Management STREAM
-
Driving Simulation Studies At Altasciences
1/30/2023
At Altasciences, we design driving studies to achieve your objectives, leveraging extensive experience across clinical testing of cognitive effects.
-
Keeping Up With ClinOps: Why And How To Improve Delivery
11/6/2023
Industry experts discuss the concept of a trial platform as a service and how it can accelerate and enhance the day-to-day functions of clinical operations throughout the entire lifecycle of a study.
-
Interview With CEO Jim Murphy: Budgeting And Fair Market Value
4/11/2022
In this interview Greenphire CEO, Jim Murphy, sits down with ClinBiz Founder and CEO, Debora Araujo to discuss critical challenges related to clinical trial planning and startup.
-
Perceptive eClinical
11/11/2024
Learn about a randomization and trial supply management (RTSM) solution that helps keep your trial on track.
-
CTIS Master Series 1: Are You Ready For CTIS?
3/22/2022
In this informative webinar, clinical trial disclosure experts Francine Lane and Thomas Wicks provide a high-level overview of EU CTR/CTIS regulations, show how they differ from the EU CTD directive, share timelines for compliance, and discuss the scope of data sharing.
-
End-To-End Clinical Data Flow
6/24/2024
Explore the interconnected data flow across Veeva Vault EDC, Veeva CDB, Veeva RTSM, and Veeva ePRO to visualize how these products work together seamlessly.
-
Do Mobile Visits Drive Faster Study Results?
2/27/2024
Discover solutions to clinical trial challenges — this on-demand webinar by PCM Trials and Clinical Leader offers insights into the role of mobile nurse visits in overcoming patient dropout and trial delays.
-
4 Insights For 2024: An Interview With Ken Getz And Jim Murphy
2/28/2024
Watch this presentation to gain a comprehensive understanding of the future direction of clinical trials and the latest developments in the industry.
-
Disclosure As A Service ROI
6/3/2020
How do sponsors determine the ROI of Disclosure as a Service? TrialScope talks with two sponsors – a large pharmaceutical company and a smaller biotech – for their take on this. Watch the short video.
-
Navigating Early Phase CNS-Active Drug Development
2/14/2023
Early development of CNS-active drugs requires in-depth clinical expertise. Altasciences’ Dr. Beatrice Setnik, Chief Scientific Officer, examines the strategies to ensure early comprehensive data collection to fulfill regulatory requirements and aid in evaluating the risk/benefit profile.